Grant: Discovery Grants Program - Individual
University of Toronto
$69,000.00
Next Generation Drug Screening by NMR and Fluorescence Spectroscopy
FY 2024-25
Summary
Background. Two mainstays of drug screening include fluorescence and NMR. While fluorescence methods are often target-specific, NMR has problem of being precise but considerably lower in sensitivity.
Technology. We propose new NMR reporters to better assess structure activity relationships (SAR) in drug screening and new fluorescent tags to provide a high-throughput readout of drug binding, positioning trainees at the forefront of drug discovery and structural biology initiatives.
1. Next-generation reporters for 19F NMR can be site-specifically introduced to the target protein to better discern conformational response to drug leads. Each of these reporters incorporates a dynamic chemical scaffold (pyridone, cyclohexane, or phenyl propane) which amplifies overall chemical shift sensitivity. Essentially microenvironments modulate the scaffold structure which modulates the 19F chemical shift. This vastly improves resolution of protein functional states and detection of ligand binding by 19F NMR.
2. Biosynthetic labeling of proteins via tryptophan (Trp) analogues. Trp is a critical residue in catalytic centers, functional motifs, and allostery. As 13C-Methyl TROSY receptivity effectively exceeds that of 19F NMR by orders of magnitude, we developed a method to incorporate 5-13CH3-Trp into any protein. Using a Trp auxotroph of E coli containing an additional plasmid for a modified Trp-tRNA-synthetase (TrpRS) we obtain full incorporation of methyl-Trp. We also synthesized 5-13CH3-d5-indole, which is metabolized to Trp. Biosynthetic labeling is highly efficient and extremely affordable, while assignments can be achieved through chemical shift predictions and 13C-edited NOESY distance measurements. We will implement this new labeling technology in an important drug target, WDR5, a 332-residue protein containing 10 Trp residues. We will profile functional states and screen conformational and dynamic response to lead compounds. We will scale up our synthesis of 13CH3-indole, improve our expression strains, and clone the identical technology in yeast to enable universal adoption of methyl-TROSY NMR via 5-CH3-Trp.
3. Target-agnostic plate-reader drug screening assays via solvatochromic fluorophores (SFs). SFs that are analogues of dyes such as prodan, exhibit pronounced extinction coefficients and large fluorescence emission shifts as a function of polarity. Upon engineering a cysteine mutant at a site of interest, a thiol-reactive SF can be installed. Electrostatic perturbations associated with ligand binding in the vicinity of the fluorophore should result in pronounced changes in the fluorescent emission spectra, allowing for drug screening or SAR studies. Intrinsic Trp fluorescence is often used to study protein folding or SAR. While the Trp extinction coefficient is abysmal, the Trp analogues (4-CN-Trp and 6-CN-Trp) are ~7x brighter. We will evolve TrpRS to incorporate 6-CN-Trp as fluorescent reporters or employ these Trp analogues as tags.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2024-05505
Name nom
Prosser, Robert
Department département
Chemistry
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
69000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3404
Research subject group en
Physical chemistry
Research subject group fr
Chimie physique
Research subject en
Biophysical chemistry
Research subject fr
Chimie biophysique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Next Generation Drug Screening by NMR and Fluorescence Spectroscopy
Keywords
characterization of proteins by nmr; drug screening by nmr and fluorescence spectroscopy; protein spectroscopy; 19f and 13c nmr technologies; biosynthetic labeling and novel amino acid analogues; solvatochromism
Application summary
Background. Two mainstays of drug screening include fluorescence and NMR. While fluorescence methods are often target-specific, NMR has problem of being precise but considerably lower in sensitivity.
Technology. We propose new NMR reporters to better assess structure activity relationships (SAR) in drug screening and new fluorescent tags to provide a high-throughput readout of drug binding, positioning trainees at the forefront of drug discovery and structural biology initiatives.
1. Next-generation reporters for 19F NMR can be site-specifically introduced to the target protein to better discern conformational response to drug leads. Each of these reporters incorporates a dynamic chemical scaffold (pyridone, cyclohexane, or phenyl propane) which amplifies overall chemical shift sensitivity. Essentially microenvironments modulate the scaffold structure which modulates the 19F chemical shift. This vastly improves resolution of protein functional states and detection of ligand binding by 19F NMR.
2. Biosynthetic labeling of proteins via tryptophan (Trp) analogues. Trp is a critical residue in catalytic centers, functional motifs, and allostery. As 13C-Methyl TROSY receptivity effectively exceeds that of 19F NMR by orders of magnitude, we developed a method to incorporate 5-13CH3-Trp into any protein. Using a Trp auxotroph of E coli containing an additional plasmid for a modified Trp-tRNA-synthetase (TrpRS) we obtain full incorporation of methyl-Trp. We also synthesized 5-13CH3-d5-indole, which is metabolized to Trp. Biosynthetic labeling is highly efficient and extremely affordable, while assignments can be achieved through chemical shift predictions and 13C-edited NOESY distance measurements. We will implement this new labeling technology in an important drug target, WDR5, a 332-residue protein containing 10 Trp residues. We will profile functional states and screen conformational and dynamic response to lead compounds. We will scale up our synthesis of 13CH3-indole, improve our expression strains, and clone the identical technology in yeast to enable universal adoption of methyl-TROSY NMR via 5-CH3-Trp.
3. Target-agnostic plate-reader drug screening assays via solvatochromic fluorophores (SFs). SFs that are analogues of dyes such as prodan, exhibit pronounced extinction coefficients and large fluorescence emission shifts as a function of polarity. Upon engineering a cysteine mutant at a site of interest, a thiol-reactive SF can be installed. Electrostatic perturbations associated with ligand binding in the vicinity of the fluorophore should result in pronounced changes in the fluorescent emission spectra, allowing for drug screening or SAR studies. Intrinsic Trp fluorescence is often used to study protein folding or SAR. While the Trp extinction coefficient is abysmal, the Trp analogues (4-CN-Trp and 6-CN-Trp) are ~7x brighter. We will evolve TrpRS to incorporate 6-CN-Trp as fluorescent reporters or employ these Trp analogues as tags.